Maeve O'Meara Oncology Institute, Inc. (TOI) insider trading activity

TOI Quotes by TradingView

Maeve O'Meara is Director of Oncology Institute, Inc.. Currently has a direct ownership of 109,104 shares of TOI, which is worth approximately $52,369. The most recent transaction as insider was on Dec 26, 2023, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
0% 3M change
84.6% 12M change
Total Value Held $52,369

Maeve O'Meara Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 31.43%
109,104 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
16,404 Added 21.72%
59,104 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
22,708 Added 34.72%
42,700 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
19,992 Added 50.0%
19,992 Common Stock

Also insider at

CSLT
CASTLIGHT HEALTH, INC.
Chief Executive Officer
MO

Maeve O'Meara

Director
San Francisco, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TOI